We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Influence of Kinesio Tapping on Quadriceps Muscle Peak Torque and Bioelectrical Activity After Meniscectomy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05715177
Recruitment Status : Completed
First Posted : February 6, 2023
Last Update Posted : March 21, 2023
Sponsor:
Information provided by (Responsible Party):
Mohamed Moustafa Mohamed Ahmed, University of Jazan

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
A Pretest post-test control group design will be used to investigate the effect of kinesio taping on electrical activity and peak torque of the quadriceps femoris muscle during concentric and eccentric contraction after arthroscopic partial meniscectomy (APM) surgery.

Condition or disease Intervention/treatment Phase
Meniscus Tear Other: Cura Kinesio-taping Other: Placebo kinesio-taping Not Applicable

Detailed Description:

One hundred thirty-two patients after APM of any knee of both sexes will participate in this study after signing a written informed consent form approved.

from the ethical committee of Jazan University. They are selected according to the following Inclusion criteria:

  1. All performed APM only without any other knee injury.
  2. Finished the period of hospital stay (6-8 weeks)
  3. Their age ranged from 20-40.
  4. Their Body mass index ranged from 20-24.9 kg/m². 2- The subjects will be excluded from the study if they had one of th e following exclusion criteria: a- Knee or quadriceps disorders preventing physical stress. b- Subjects with cardiovascular or neurological problems. c- Smokers. d- Heavy caffeine intake subjects. 3- The subjects will be randomly assigned into two groups of equal numbers. Group A (Study) consisted of 66 subjects who will receive kinesio-taping from origin to insertion on the superficial muscles of the Quadriceps femoris (QF) (Vastus Medialis (VM), Vastus Lateralis (VL), Rectus Femoris (RF)). - Group B (Control) consisted of 66 subjects who will receive a placebo kinesio-taping across quadriceps. Anthropometric measures including "weight and height" and body. mass index (BMI) will be measured for all subjects in the first meeting before starting the evaluative procedures. All subjects were asked to shave the hair of their thigh before starting the evaluative procedure using blades, which was essential to prevent artifact during EMG evaluation and to facilitate the adherence of the tape to the skin. Bioelectrical activity and peak torque of quadriceps muscle of the lower extremity that had APM will be measured. The evaluation will be carried out before tapping, and then after the application of tapping for 10 minutes.
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 132 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: A Pretest post-test control group design will be used to investigate the effect of kinesio-taping on electrical activity and peak torque of the quadriceps femoris muscle during concentric and eccentric contraction after arthroscopic partial meniscectomy (APM) surgery
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Influence of Kinesio Tapping on Quadriceps Muscle Peak Torque and Bioelectrical Activity After Arthroscopic Partial Meniscectomy (RTC)
Actual Study Start Date : February 6, 2023
Actual Primary Completion Date : February 26, 2023
Actual Study Completion Date : March 5, 2023
Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Cura kinesio-taping
consisted of 66 subjects who will receive kinesio-taping from origin to insertion on the superficial muscles of Quadriceps femoris (QF) (Vastus Medialis (VM), Vastus Lateralis (VL), Rectus Femoris (RF)
 Other: Cura Kinesio-taping
Cura tapes, a cotton strip with an acrylic adhesive. allows for unidirectional elasticity up to 60% beyond its resting length will be applied on origin to insertion on the superficial muscles of Quadriceps femoris (QF) (Vastus Medialis (VM), Vastus Lateralis (VL), Rectus Femoris (RF)
Placebo Comparator: Placebo kinesio-taping
consisted of 66 subjects who will receive placebo kinesio-taping across quadriceps.
 Other: Placebo kinesio-taping
Placebo kinesiotaping


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Peak muscle torque [ Time Frame: 1. Baseline: before tapping 2. after10 minutes of Cura kinesio-taping. ]
    Peak torque of the quadriceps femoris muscle during concentric and eccentric contraction after arthroscopic partial meniscectomy (APM) surgery using Biodex system

  2. Bioelectrical activity of quadriceps muscle [ Time Frame: 1. Baseline: before tapping 2. after10 minutes of Cura kinesio-taping. ]

    bioelectrical activity of the three quadriceps muscle heads will be measured. All subjects were asked to shave the hair of their thigh before starting.

    the evaluative procedure using blades, which was essential to prevent artifact during EMG evaluation and to facilitate the adherence of the tape to the skin



Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 40 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Clinical diagnosis only with arthroscopic partial meniscectomy
  2. Must be finished a period of hospital stay (6-8 weeks)
  3. Must have body mass index ranged from 20-24.9 kg/m².

Exclusion Criteria:

a. Knee or quadriceps disorders preventing physical stress. b- Cardiovascular or neurological problems. c- Smokers d- Heavy caffeine intake subjects.

Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05715177


Locations
Layout table for location information
Saudi Arabia
Jazan University
Jazan, Gizan, Saudi Arabia, 45142
Sponsors and Collaborators
University of Jazan
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Mohamed Moustafa Mohamed Ahmed, Assistant profosser of Biomechanics faculty of applied medical sciences, Jazan University KSA., University of Jazan
ClinicalTrials.gov Identifier: NCT05715177    
Other Study ID Numbers: 1147
First Posted: February 6, 2023    Key Record Dates
Last Update Posted: March 21, 2023
Last Verified: March 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No